Viani Gustavo Arruda, Arruda Caio Viani, Faustino Alexandre Ciufi, De Fendi Ligia Issa
Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo (FMRP-USP), Ribeirão Preto, São Paulo, Brazil.
Bioscience Institute of University of State from Sao Paulo (UNESP), Botucatu, São Paulo, Brazil.
Brachytherapy. 2020 Jul-Aug;19(4):491-498. doi: 10.1016/j.brachy.2020.03.003. Epub 2020 Apr 24.
The purpose of this study was to compare the treatment outcomes of partial-breast irradiation (PBI) versus whole-breast radiotherapy (WBRT) in early breast cancer.
Eligible randomized clinical trials were identified on Medline, Embase, the Cochrane Library, and the proceedings of annual meetings through December 2019. A meta-analysis for local recurrence (LR), overall mortality (OM), and non-breast cancer mortality (NBCM) was conducted. When possible, the outcomes were calculated for 5, 7, and 10 years of followup. A subgroup analysis by PBI technique (brachytherapy [BT], external beam radiotherapy [EBRT], intraoperative radiotherapy [IORT], and mixed) was performed. A p value < 0.05 was considered significant.
Eleven randomized clinical trials with a total of 14,436 patients (7186 PBI vs. 7250 WBRT) were included in the meta-analysis. The odds ratio (OR) for LR in 5 y was 1.46 (95% CI 1.15-2, p = 0.024) for PBI. In the subgroup analysis, no significant difference for LR was observed between PBI and WBRT using BT (p = 0.51), EBRT (p = 0.25), or mixed techniques (p = 0.89). The only subgroup with statistical difference was IORT 3.1 (95% CI 1.2-7.6, p = 0.014). No significant difference in LR was observed with 7 and 10 years among the groups. The OM had no difference at 5, 7, and 10 years of followup for any subgroup. A nonsignificant difference was observed comparing PBI with WBRT for NBCM OR = 1.24 (95% CI 0.98-1.57, p = 0.07). The rates of cardiac death, contralateral breast cancer, and development of second tumor were not significant.
The LR with PBI is low and similar to WBRT in selected early breast cancer with a longer followup. The subgroup analysis detected a significant difference for LR associated with IORT and no significant difference for BT and EBRT. Our results confirm a nonsignificant difference for OM and NBCM between PBI and WBRT.
本研究旨在比较早期乳腺癌患者接受部分乳腺照射(PBI)与全乳放疗(WBRT)的治疗效果。
通过检索Medline、Embase、Cochrane图书馆以及截至2019年12月的年会论文集,确定符合条件的随机临床试验。对局部复发(LR)、总死亡率(OM)和非乳腺癌死亡率(NBCM)进行荟萃分析。可能的情况下,计算随访5年、7年和10年的结果。按PBI技术(近距离放疗[BT]、外照射放疗[EBRT]、术中放疗[IORT]及混合技术)进行亚组分析。p值<0.05被认为具有统计学意义。
荟萃分析纳入了11项随机临床试验,共14436例患者(7186例接受PBI,7250例接受WBRT)。PBI组5年局部复发的比值比(OR)为1.46(95%CI 1.15 - 2,p = 0.024)。亚组分析中,采用BT(p = 0.51)、EBRT(p = 0.25)或混合技术(p = 0.89)时,PBI与WBRT之间局部复发无显著差异。唯一有统计学差异的亚组是IORT 3.1(95%CI 1.2 - 7.6,p = 0.014)。各亚组在7年和10年时局部复发无显著差异。任何亚组在随访5年、7年和10年时总死亡率均无差异。PBI与WBRT比较,非乳腺癌死亡率OR = 1.24(95%CI 0.98 - 1.57,p = 0.07),差异无统计学意义。心脏死亡、对侧乳腺癌及第二原发肿瘤的发生率无显著差异。
在随访时间较长的特定早期乳腺癌患者中,PBI的局部复发率较低且与WBRT相似。亚组分析发现IORT相关的局部复发有显著差异,而BT和EBRT无显著差异。我们的结果证实PBI与WBRT在总死亡率和非乳腺癌死亡率方面无显著差异。